Prana Therapeutics Inc
Clinical trials sponsored by Prana Therapeutics Inc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New asthma drug shows promise in early human trials Results expected Oct 2026 (estimated)
- Can a new biologic calm airway inflammation in COPD? Results expected Jun 2027 (estimated)
- New biologic PRA-216 put to the test against stubborn eczema Results expected Jun 2027 (estimated)
-
Can a new biologic calm airway inflammation in COPD?
Disease control Not yet recruitingThis phase 2 trial is testing whether an experimental drug called PRA-216 can safely reduce airway inflammation in people with moderate to severe COPD who have a specific type of inflammation (type 2). Participants will receive either PRA-216 or a placebo, and researchers will mo…
Phase 2 • Sponsor: Prana Therapies Inc • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New biologic PRA-216 put to the test against stubborn eczema
Symptom relief Not yet recruitingResearchers are testing an experimental biologic drug called PRA-216 in adults with moderate to severe atopic dermatitis, a form of eczema. The trial compares PRA-216 with a placebo to see whether the drug is safe and can reduce eczema severity. Participants must have had eczema …
Phase 2 • Sponsor: Prana Therapies Inc • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC